Monday, July 9, 2007

Alnylam Pharmaceuticals, Lexmark, Roche, SonoSite: U.S. Equity Preview

(Bloomberg) -- The following is a list of companies
whose shares may have unusual price changes in U.S. exchanges.
This preview includes news that broke after exchanges closed on
July 6. Stock symbols are in parentheses after company names.
Share prices are as of 7:30 a.m. New York time.

Alnylam Pharmaceuticals Inc. (ALNY US) rose $7.65, or 50
percent, to $22.85 in trading before U.S. exchanges opened. Roche
Holding AG (RHHBY US), the world's biggest maker of cancer
medicines, said it may pay as much as $1 billion for rights to
Alnylam Pharmaceuticals technology that may allow the companies
to find new tumor, liver and breathing treatments. Alnylam will
get a cash payment of $288.5 million and will sell Roche about 2
million shares for $42.5 million. The stock represents just less
than a 5 percent stake in Alnylam, Roche said.


Read more at Bloomberg Stocks News

No comments: